Center for Devices and Radiological Health 510(k) Clearance Process; Recommendations Proposed in Institute of Medicine Report: “Medical Devices and the Public's Health, The FDA 510(k) Clearance Process at 35 Years”; Public Meeting; Correction, 54777 [2011-22475]
Download as PDF
erowe on DSK5CLS3C1PROD with NOTICES
Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices
annual update to the standard Federal
rate for discharges occurring during a
rate year, beginning in FY 2014. One of
the quality measures LTCHs are
required to collect and submit data on
is the Percent of Residents with Pressure
Ulcers That Are New or Have Worsened.
Currently, there are no mandatory
standardized data sets being used in
LTCHs. Therefore, we have created a
new data set to be used in LTCHs,
which incorporates data items
contained in other, well known and
clinically established pressure ulcer
data sets, including but not limited to
the Minimum Data Set 3.0 (MDS 3.0)
and CARE data set (Continuity
Assessment Records & Evaluation).
Beginning on October 1, 2012, LTCHs
will begin to use a data collection
document entitled the ‘‘LTCH CARE
Data Set’’ as the vehicle by which to
collect the pressure ulcer data for the
LTCH quality reporting program. This
data set consists of the following
components: (1) Pressure ulcer
documentation; (2) selected covariates
related to pressure ulcers; (3) patient
demographic information; and; (4) a
provider attestation section. The use of
the LTCH CARE Data Set is necessary in
order to allow CMS to collect LTCH
quality measures data in compliance
with Section 3004 of the Affordable
Care Act. There are no other reasonable
alternatives available to CMS for the
collection and submission of pressure
ulcer data. Form Number: CMS–10409
(OCN: 0938–New); Frequency:
Occasionally; Affected Public: Private
Sector: Business or other for-profit and
not-for-profit institutions; Number of
Respondents: 3,531; Total Annual
Responses: 3,531; Total Annual Hours:
883. (For policy questions regarding this
collection contact Caroline Gallaher at
410–786–8705. For all other issues call
410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
e-mail your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by November 1, 2011:
1. Electronically. You may submit
your comments electronically to https://
VerDate Mar<15>2010
15:37 Sep 01, 2011
Jkt 223001
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number llllll, Room
C4–26–05, 7500 Security Boulevard,
Baltimore, Maryland 21244–1850.
54777
‘‘Will there be transcripts of the
meeting?’’ the address for the Division
of Freedom of Information is corrected
to read ‘‘Division of Freedom of
Information (ELEM–1029), Food and
Drug Administration, 12420 Parklawn
Dr., Element Bldg., Rockville, MD
20857.’’
Dated: August 29, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices
and Radiological Health.
[FR Doc. 2011–22475 Filed 9–1–11; 8:45 am]
Dated: August 30, 2011.
Martique Jones,
Director, Regulations Development Group,
Division B, Office of Strategic Operations and
Regulatory Affairs.
BILLING CODE 4160–01–P
[FR Doc. 2011–22583 Filed 9–1–11; 8:45 am]
Food and Drug Administration
BILLING CODE 4120–01–P
[Docket No. FDA–2011–N–0002]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Request for Nominations for Voting
Members on a Public Advisory
Committee; Tobacco Products
Scientific Advisory Committee
[Docket No. FDA–2011–N–0556]
AGENCY:
Center for Devices and Radiological
Health 510(k) Clearance Process;
Recommendations Proposed in
Institute of Medicine Report: ‘‘Medical
Devices and the Public’s Health, The
FDA 510(k) Clearance Process at 35
Years’’; Public Meeting; Correction
ACTION:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA) is correcting a
notice that appeared in the Federal
Register of Friday, August 12, 2011 (76
FR 50230). The document announced a
public workshop entitled
‘‘Recommendations Proposed in
Institute of Medicine Report: ‘Medical
Devices and the Public’s Health, The
FDA 510(k) Clearance Process at 35
Years.’ ’’ The document was published
with an outdated address in the section
entitled ‘‘Will there be transcripts of the
meeting?’’ This document corrects that
error.
FOR FURTHER INFORMATION CONTACT:
Joyce Strong, Office of Policy, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 32, Rm. 3208,
Silver Spring, MD 20993–0002, 301–
796–9148.
SUPPLEMENTARY INFORMATION: In FR Doc.
2011–20575, appearing on page 50230
in the Federal Register of Friday,
August 12, 2011, the following
correction is made:
1. On page 50231, in the second
column, under the section entitled
SUMMARY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA) is requesting
nominations for members to serve on
the Tobacco Products Scientific
Advisory Committee, Center for
Tobacco Products.
FDA has a special interest in ensuring
that women, minority groups, and
individuals with disabilities are
adequately represented on advisory
committees and, therefore, encourages
nominations of qualified candidates
from these groups.
DATES: Nominations received on or
before November 1, 2011 will be given
first consideration for membership on
the Tobacco Products Scientific
Advisory Committee. Nominations
received after November 1, 2011 will be
considered for nomination to the
committee if nominees are still needed.
ADDRESSES: All nominations for
membership should be sent
electronically to cv@oc.fda.gov, or by
mail to Advisory Committee Oversight
and Management Staff, 10903 New
Hampshire Ave., Bldg. 32, Rm. 5103,
Silver Spring, MD 20993–0002.
FOR FURTHER INFORMATION CONTACT:
Regarding all nomination questions
for membership, the primary contact is:
Caryn Cohen, Office of Science,
Center for Tobacco Products, Food and
Drug Administration, 9200 Corporate
Blvd., Rockville, MD 20850, 1–877–
287–1373 (choose Option 4), FAX: 240–
276–3761, TPSAC@fda.hhs.gov.
SUMMARY:
E:\FR\FM\02SEN1.SGM
02SEN1
Agencies
[Federal Register Volume 76, Number 171 (Friday, September 2, 2011)]
[Notices]
[Page 54777]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22475]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0556]
Center for Devices and Radiological Health 510(k) Clearance
Process; Recommendations Proposed in Institute of Medicine Report:
``Medical Devices and the Public's Health, The FDA 510(k) Clearance
Process at 35 Years''; Public Meeting; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is correcting a notice
that appeared in the Federal Register of Friday, August 12, 2011 (76 FR
50230). The document announced a public workshop entitled
``Recommendations Proposed in Institute of Medicine Report: `Medical
Devices and the Public's Health, The FDA 510(k) Clearance Process at 35
Years.' '' The document was published with an outdated address in the
section entitled ``Will there be transcripts of the meeting?'' This
document corrects that error.
FOR FURTHER INFORMATION CONTACT: Joyce Strong, Office of Policy, Food
and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, Rm. 3208,
Silver Spring, MD 20993-0002, 301-796-9148.
SUPPLEMENTARY INFORMATION: In FR Doc. 2011-20575, appearing on page
50230 in the Federal Register of Friday, August 12, 2011, the following
correction is made:
1. On page 50231, in the second column, under the section entitled
``Will there be transcripts of the meeting?'' the address for the
Division of Freedom of Information is corrected to read ``Division of
Freedom of Information (ELEM-1029), Food and Drug Administration, 12420
Parklawn Dr., Element Bldg., Rockville, MD 20857.''
Dated: August 29, 2011.
Nancy K. Stade,
Deputy Director for Policy, Center for Devices and Radiological Health.
[FR Doc. 2011-22475 Filed 9-1-11; 8:45 am]
BILLING CODE 4160-01-P